The Most Obvious Reason to Buy Domino's Pizza (DPZ) Stock Before It Reports Earnings on July 20 Is Hiding in Plain Sight There are thousands of companies that most of us know little about -- which can make them more risky investments for us. Some, though, are quite familia
Stifel analysts highlight Hayward Holdings as a beneficiary of Pentair’s reduced guidance due to company-specific challenges in pool equipment. Hayward Holdings (HAYW) is positioned to capture market share from Pentair (PNR) after Pentair lowered its full-year outlook, cit
Corning shares face pressure as JPMorgan cites elevated valuation ahead of second-quarter results, not performance issues. JPMorgan placed Corning (GLW) on its Negative Catalyst Watch list, citing concerns over the company’s high valuation rather than operational performan
Eli Lilly will acquire AtaiBeckley for $6.75 per share plus up to $2.50 in contingent value rights, expanding its neuroscience pipeline. Eli Lilly and Co will acquire AtaiBeckley Inc. in a deal valued at up to $3.8 billion, including $2.8 billion in upfront cash and potent
A $10,000 investment in JPMorgan at Dimon's 2005 CEO start now exceeds $147K, outpacing the S&P 500 by nearly 3x. A $10,000 investment in JPMorgan Chase when Jamie Dimon became CEO on December 31, 2005, has grown to $147,285, reflecting a 1,373% return. The S&P 500 deliver
Chipmakers compete to dominate the growing AI inference market, expected to surpass training in size, with distinct memory-focused strategies. Nvidia, AMD, and Cerebras Systems are positioning to lead the AI inference chip market, projected to outpace training in scale. In
The acquisition aims to expand Uber Eats into 50 new markets following $42 billion in gross bookings last year. Uber Technologies will purchase German food delivery firm Delivery Hero for $14.8 billion, marking its largest acquisition to date. The deal values Delivery Hero
The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative. If you hold Elevance Health (ELV) stock, you've been rewarded for believing in a well-run, diversified health insurer The sto
The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story. At a glance, CVS Health (CVS) stock looks expensive Trading at about $105.91, its trailing twelve months price-to-earnings ratio sits
If you hold the shares, you are already exposed to the full, sizable gap between two very different potential outcomes. The options market sees two very different destinations for Microsoft (MSFT) stock a year from now: one near $280, the other near $565 From today'
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.